BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18473841)

  • 1. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
    Rodrigues JC; de Souza W
    Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill.
    Vannier-Santos MA; De Castro SL
    Curr Drug Targets; 2009 Mar; 10(3):246-60. PubMed ID: 19275561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to the structural organization of parasitic protozoa.
    de Souza W
    Curr Pharm Des; 2008; 14(9):822-38. PubMed ID: 18473832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.
    Docampo R; Moreno SN
    Curr Pharm Des; 2008; 14(9):882-8. PubMed ID: 18473837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New mechanisms of drug resistance in parasitic protozoa.
    Borst P; Ouellette M
    Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
    Hammarton TC; Mottram JC; Doerig C
    Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
    Sen N; Majumder HK
    Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
    Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
    Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J
    Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting polyamines of parasitic protozoa in chemotherapy.
    Müller S; Coombs GH; Walter RD
    Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
    Harder A; Greif G; Haberkorn A
    Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosomiais and leishmaniasis "recent development in the chemotherapy of infectious diseases caused by parasitic protozoa".
    de Souza W
    Curr Pharm Des; 2008; 14(9):821. PubMed ID: 18473831
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cell cycle in the pursuit of novel chemotherapies against parasitic protozoa.
    Grant KM
    Curr Pharm Des; 2008; 14(9):917-24. PubMed ID: 18473840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA topoisomerases as targets for antiprotozoal therapy.
    Bakshi RP; Shapiro TA
    Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of microscopy to a better understanding of the anatomy of pathogenic protists.
    de Souza W
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321515121. PubMed ID: 38621128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs targeting parasite lysosomes.
    Doyle PS; Sajid M; O'Brien T; Dubois K; Engel JC; Mackey ZB; Reed S
    Curr Pharm Des; 2008; 14(9):889-900. PubMed ID: 18473838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
    Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
    Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABC transporters and drug resistance in parasitic protozoa.
    Klokouzas A; Shahi S; Hladky SB; Barrand MA; van Veen HW
    Int J Antimicrob Agents; 2003 Sep; 22(3):301-17. PubMed ID: 13678838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of farnesyl pyrophosphate synthase from parasitic protozoa, a potential chemotherapeutic target.
    Srivastava A; Mukherjee P; Desai PV; Avery MA; Tekwani BL
    Infect Disord Drug Targets; 2008 Mar; 8(1):16-30. PubMed ID: 18473904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.